Inmarsat’s Fastest Ever Inflight Broadband Plans Are Now Available for Business Aviation Customers
23.5.2023 09:00:00 CEST | Business Wire | Press Release
Inmarsat has announced the next chapter of its market-leading Jet ConneX (JX) inflight broadband solution, with a new range of service plans introduced to redefine gold standard connectivity in the business aviation market and satisfy even the most data-hungry users for many years to come.
Launched as part of Inmarsat’s JX Evolution programme, these latest service plans are available for new and existing customers to order today, marking a step-change in performance that is backed by guaranteed speeds and Inmarsat’s hallmark consistent customer experience.
The new service plans offer enhanced performance using Jet ConneX’s existing, highly successful JetWave terminal by Inmarsat’s partner Honeywell, and will also be compatible with three upcoming next-generation terminals being developed by Satcom Direct, Orbit and Honeywell. Satcom Direct’s Plane Simple Ka-band system has commenced flight testing and is expected to enter service later this year.
All three next-generation terminals use innovative technology and lightweight designs to optimise performance, reduce costs, and simplify installation and maintenance. Their reduced size and weight make them suitable for various types of business jets, creating new opportunities in the fast-growing super midsize aircraft market, which shares many of the same connectivity requirements as large aircraft.
Jet ConneX customers will also benefit from seven more Inmarsat satellite payloads entering service by 2025, increasing its Ka-band network fleet to 12. This includes two Inmarsat-6s, both of which have already launched, followed by two payloads in highly elliptical orbit, enabling the world’s only commercial mobile broadband service for flights in higher latitudes and across the Arctic. Three additional satellites will then launch in geostationary orbit, adding further speed, capacity, and resilience.
The combination of next generation terminals and Inmarsat’s fast-growing satellite network will enable speeds up to 100 Mbps, for top tier customers that demand the highest level ‘office-in-the-sky’ experience.
The new Jet ConneX service plans are available through Inmarsat’s global business aviation distribution network, which consists of Satcom Direct, Collins Aerospace and Honeywell.
Kai Tang, Inmarsat’s Head of Business Aviation, said “Jet ConneX is renowned for delivering a very high standard of service and these transformative new plans once again highlight Inmarsat’s continued focus on staying ahead of market expectations. This provides customers with reassurance that our connectivity will keep pace with their long-term needs. Importantly, as these include the first plans to use our new satellites and terminals, it also offers a glimpse into future capabilities and provides certainty that their investment in our technology is future-proofed.
“These service plans have been specifically designed to deliver even greater value and performance based on unique insights into usage of our inflight broadband service. This build-up approach is unique to Inmarsat and cannot be replicated by others in the market, some of which have a tendency to over promise and under deliver, either from the start or as their networks fill and performance degrades.
“Crucially, this is only the next step for us. We will continue to assess usage and adapt accordingly, with even more flexible options to be announced later this year.”
Since entering commercial service in November 2016, Jet ConneX has been activated on more than 1,400 business jets: offering the same reliable, consistent and high-speed broadband that was previously only available on the ground. Passenger usage of Jet ConneX increased to record levels since the pandemic, testament to fast-growing expectations from users, who use everything from video streaming and live TV to conference calls and other business activities. JX’s most powerful service plans will now enable passengers to simultaneously connect more devices and enjoy unchallenged access to the most data-hungry applications - including high-definition video conferencing - without compromising on its proven characteristics of consistency, reliability, resilience, and seamless global availability.
Inmarsat’s 2023 global survey of business aviation professionals - conducted in partnership with Corporate Jet Investor (CJI) - found that 82% of respondents believe inflight connectivity has evolved from a luxury option for some, to a key requirement for the majority of passengers. The results, published at the European Business Aviation Convention & Exhibition (EBACE) this week, show the three most important factors when selecting a connectivity system, in order, were consistent performance, 100% route coverage, and high speed.
ENDS
ABOUT INMARSAT
Inmarsat delivers world leading, innovative, advanced and exceptionally reliable global, mobile communications across the world – in the air, at sea and on land - that are enabling a new generation of commercial, government and mission-critical services. Inmarsat is powering the digitalisation of the maritime industry, making operations more efficient and safer than ever before. It is driving a new era of inflight passenger services for aviation, while ensuring that aircraft can fly with maximum efficiency and safety. Furthermore, Inmarsat is enabling the rapid expansion of the Internet of Things (IoT) and enabling the next wave of world-changing technologies that will underpin the connected society and help build a sustainable future. And now Inmarsat is developing the first-of-its-kind, multi-dimensional communications network of the future, ORCHESTRA.
In November 2021, Inmarsat and Viasat announced the planned combination of the two companies, to create a new leader in global communications.
For further information, follow us: Twitter | LinkedIn | Facebook | YouTube | Instagram.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230523005098/en/
Contact information
Contact for media: press@inmarsat.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press Release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press Release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press Release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press Release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press Release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom